These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29927559)

  • 1. Immunohistochemistry of Cytokeratin 7, Cytokeratin 20 and Thyroid Transcription Factor-1 in Metastatic Carcinoma of Cervical Lymph Node Biopsy for Identification of Pulmonary Origin in Rajavithi Hospital.
    Kuakpaetoon T
    J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S172-6. PubMed ID: 29927559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
    Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
    Su YC; Hsu YC; Chai CY
    Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.
    Tsao SC; Su YC; Wang SL; Chai CY
    Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes.
    Roh MS; Hong SH
    J Korean Med Sci; 2002 Aug; 17(4):512-7. PubMed ID: 12172048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
    Al-Zahrani IH
    Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
    Cai YC; Banner B; Glickman J; Odze RD
    Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of lymph node micrometastasis at the pN₀ stage of lung adenocarcinoma using a combination of markers.
    Liu H; Ye YK; Li GM; Zhou Y; Han KB; Xu G; Wang D
    Genet Mol Res; 2014 Jul; 13(3):5594-600. PubMed ID: 25117316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma.
    Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R
    Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens.
    Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J
    Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic thoracic lymph node carcinoma of unknown origin on which we performed two kinds of immunohistochemical examinations.
    Yoshino N; Yamauchi S; Hino M; Ohaki Y; Koizumi K; Shimizu K
    Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):283-6. PubMed ID: 16977301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.
    Bayrak R; Yenidünya S; Haltas H
    Pathol Res Pract; 2011 Mar; 207(3):156-60. PubMed ID: 21282015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of thyroid transcription factor-1 in identification of the prognosis of bronchioloalveolar carcinoma].
    Wang CL; Yue DS; Zhang ZF; Zhan ZL; Sun LN
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2350-4. PubMed ID: 18036300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thyroid transcription factor-1 in pulmonary cytology].
    Smojver-Jezek S; Vrabec-Branica B; Juros Z; Boras Z; Cucević B; Mazuranić I
    Acta Med Croatica; 2008 Oct; 62(4):373-8. PubMed ID: 19205414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward an evidence-based proposal for the best minimal immunohistochemical panel to infer lung carcinoma in metastatic supraclavicular lymph node.
    Kumar R; Jambhekar NA; Marchevsky AM; Pramesh CS; Karimundackal G; Agarwal JP; Dikshit R
    Ann Diagn Pathol; 2014 Apr; 18(2):53-7. PubMed ID: 24360802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer.
    Luo HT; Liang CX; Luo RC; Gu WG
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28827446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions.
    Jang KY; Kang MJ; Lee DG; Chung MJ
    Anal Quant Cytol Histol; 2001 Dec; 23(6):400-4. PubMed ID: 11777274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms.
    Bejarano PA; Nikiforov YE; Swenson ES; Biddinger PW
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):189-94. PubMed ID: 10981870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas.
    Merchant SH; Amin MB; Tamboli P; Ro J; Ordóñez NG; Ayala AG; Czerniak BA; Ro JY
    Am J Surg Pathol; 2001 Dec; 25(12):1515-9. PubMed ID: 11717541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.